Revenue for H1 FY23 at ₹ 67.55 Crore, 50% YoY growth
EBITDA for H1 FY23 at ₹11.59 Crore, 638% YoY growth
Net Profit for H1 FY23 at ₹ 6.83 Crore, 16,975% YoY growth
Mumbai (Maharashtra) [India]: Focus Lighting & Fixtures Limited. (NSE – FOCUS), engaged in manufacturing & innovative lighting solutions of LED lights and fixtures, announced its unaudited Financial Results for the Quarter and Half Year ended September 30, 2022.
Key Financials at a Glance (Q2 FY23):
– Total Income for Q2 FY23 at ₹ 40.61 Crore against ₹ 23.15 Crore in Q2 FY22, 75% YoY growth EBITDA for Q2 FY23 at ₹ 8.30 Crore against ₹ 1.86 Crore in Q2 FY22, 346% YoY growth EBITDA Margin for Q2 FY23 at 20.44% against 8.03% in Q2 FY22, 1,240 bps YoY growth
– Net Profit for Q2 FY23 at ₹ 4.59 Crore against ₹ 1.58 Crore in Q2 FY22, 191% YoY growth
– Net Profit Margin for Q2 FY23 at 11.30% against 6.83% in Q2 FY22, 448 bps YoY growth
– EPS for Q2 FY23 at ₹ 4.53 against ₹ 1.56 in Q2 FY22, 190% YoY growth H1 FY23
– Total Income for H1 FY23 at ₹ 67.55 Crore against ₹ 45.18 Crore in H1 FY22, 50% YoY growth EBITDA for H1 FY23 at ₹ 11.59 Crore against ₹ 1.57 Crore in H1 FY22, 638% YoY growth EBITDA Margin for H1 FY23 at 17.16% against 3.47% in H1 FY22, 1,368 bps YoY growth
– Net Profit for H1 FY23 at ₹ 6.83 Crore against ₹ 0.04 Crore in H1 FY22, 16,975% YoY growth Net Profit Margin for H1 FY23 at 10.11% against 0.09% in H1 FY22, 1,002 bps YoY growth EPS for H1 FY23 at ₹ 6.74 against ₹ 0.04 in H1 FY22, 16,750% YoY growth.
Key Financial Highlights:
– For H1 FY23, Cash Flow from Operation stood at ₹ 5.02 Crore against ₹ 0.61 Crore in H1 FY22
– For H1 FY23, Revenue from Manufacturing activities contributed ₹ 49.54 Crore against ₹ 19.65 Crore in H1 FY22
– For H1 FY23, Revenue from Trading activities contributed ₹ 17.32 Crore against ₹ 25.12 Crore in H1 FY22
– For H1 FY23, Manufacturing activities contributed ₹ 8.67 Crore in PBT against a loss of ₹ 0.73 Crore in H1 FY22.
– For H1 FY23, Trading activities contributed ₹ 0.98 Crore in PBT against ₹ 1.24 Crore in H1 FY22.
Commenting on the performance, Mr. Amit Sheth, Managing Director of Focus Lighting And Fixtures, said, “For the H1 FY22, we have seen demand coming back to the pre-pandemic levels, and our margins have improved significantly on the back of diversifying into new business verticals like Projects and Railways which will also provide good margin business because of the government’s push towards increasing make in India contribution.
Also, our thrust on increasing manufacturing contribution has helped us achieve higher operating margins.
Further, our innovative lighting solutions are one of the preferred brands among leading retail giants, which has helped us increase our turnover and margins over the previous year.”
About Focus Lighting & Fixtures Limited:
Focus Lighting & Fixtures Limited (NSE – FOCUS) The company was established in 2005. The company currently provides a wide range of products which includes recessed adjustable spotlights, recessed downlights, surface-mounted spotlights, surface-mounted / suspended downlights, system-based spotlights/wall washers, track-mounted spotlights, etc., each with different working capabilities. Its comprehension of lighting technology, the influence it can have on the viewer, and the techno-aesthetic requirement of the market have enticed it to develop lighting solutions where the criteria are efficiency, color rendition and trouble-free service life to achieve optimum lighting parameters such as luminous intensity, maintenance-friendliness and freedom from glare. The new range of luminaires has been designed and developed by the finest product designers from Germany, proficient in the field of lighting design, supported by a proficient team of Indian Professionals. The company has its manufacturing unit in Sanand, Gujarat.
Post-pandemic, the Company has emerged strongly by doubling its revenues to ₹ 106.6 Crore in FY22 compared with ₹ 60.84 Crore in FY21, while the bottom line is back in the black at ₹ 4.10 Crore as against a loss of ₹ 2.28 Crore in the same period.
If you have any objection to this press release content, kindly contact firstname.lastname@example.org to notify us. We will respond and rectify the situation in the next 24 hours.
The post Focus Lighting H1 FY23 EBITDA up by 638% appeared first on City Lights.
cost of sildenafil viagra near me viagra from india
viagra femenino sildenafil citrate 50mg buy viagra online
herbal viagra snorting viagra woman viagra
amazon viagra levitra vs viagra generic viagra online
Ivermectin spray Buy Stromectol 6 mg – What is the number one best probiotics
Can you get asthma inhalers for free ipratropium albuterol?
How do you make amoxicillin stromectol dosage demodex – https://www.stromectolus.com/
What should I avoid when I’m on antibiotics stromectol 3 mg tablets?
clomid dosage for men with low testosterone
hydroxychloroquine 200mg tablets how does plaquenil work plaquenil overdose
What happens if schizophrenia is left untreated abilify 10 mg tablet?
How do you know if your love will last cialis without a prescription
Drugs message sheet. What side effects can this medication cause? viagra cost walmart Rout telecast nearly drugs. Get back at here.
lasix loop diuretic torsemide vs furosemide furosemide torsemide conversion
Can flexiril get you High cost of ventolin hfa inhaler
metronidazole oxidation metronidazole gel prescribed for metronidazole do not drink alcohol
Do antibiotics raise blood pressure hydroxychloroquine studies
Medicines message for patients. Effects of Hypnotic Abuse. In US stromectol dosing All bulletin around medicine. Understand information now.
stromectol austria buy stromectol 3mg stromectol cvs
cialis 20 mg prix cialis achat https://cialis10fr.com/
mexican z pack dosage dosage for azithromycin allergic to azithromycin
Medicine report recompense patients. Cautions. legitimate canadian pharmacy online Some what you want to separate hither medicines. Have in mind now.
buy propecia over the counter where to buy propecia without insurance buy propecia without prescription
Can your liver hurt in your back | Azithromycin tablet
Take azithromycin (also called вЂњZithromaxвЂќ) to cure gonorrhea. Zithromax and cefixime (cefpodoxime if you happen to get that instead) are very safe medicines.
How long should a man last to please a woman?
http://www.coxengineering.com/?URL=https://zithromaxotc.com Azithromycin tablet